Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006291036> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W3006291036 endingPage "45" @default.
- W3006291036 startingPage "36" @default.
- W3006291036 abstract "30% of people with schizophrenia do not respond to antipsychotics. In these cases, treatment with clozapine is indicated, but only 40% of this subpopulation responds to treatment, thus forming a subgroup of resistant patients who do not respond to clozapine and are therefore referred to as ultra-resistant. Between 12 and 20% of people with schizophrenia are ultra-resistant. The objective of this work is to review the possible treatment for ultra-resistance and its scientific evidence. From the review carried out, it is clear that: 1) The addition of a second antipsychotic to clozapine has a partial response, and there is no antipsychotic that shows significant difference compared to others. 2) Of the antiepileptics, the one that generates a slight clinical improvement is sodium valproate, but even so, a complete response is not achieved. Lamotrigine, in turn, generates a therapeutic response in studies with mild to moderately symptomatic patients. 3) The use of inhibitors of d-amino oxidase, such as sodium benzoate, only achieved a slight clinical improvement without achieving a comprehensive therapeutic response. 4) The addition of memantine was not effective. 5) The addition of electroconvulsive therapy generates significant therapeutic response in severely symptomatic patients for both the positive and negative symptomatic dimensions. Electroconvulsive therapy does not generate cognitive alterations, produces improvement in immediate and long-term verbal memory and in executive functions. Currently more robust evidence concerning therapeutic approaches to ultrarresistant schizophrenia are lacking. In particular, randomized and controlled studies with significant number of patients will be valuable of help to make decisions in this subpopulation with an important impairment in their functionality and quality of life." @default.
- W3006291036 created "2020-02-24" @default.
- W3006291036 creator A5077963788 @default.
- W3006291036 date "2020-01-23" @default.
- W3006291036 modified "2023-09-23" @default.
- W3006291036 title "[Approaches for the treatment of people with schizophrenia that do not respond to clozapine or ultra-resistant schizophrenia. Review of the evidence.]" @default.
- W3006291036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31968029" @default.
- W3006291036 hasPublicationYear "2020" @default.
- W3006291036 type Work @default.
- W3006291036 sameAs 3006291036 @default.
- W3006291036 citedByCount "1" @default.
- W3006291036 countsByYear W30062910362022 @default.
- W3006291036 crossrefType "journal-article" @default.
- W3006291036 hasAuthorship W3006291036A5077963788 @default.
- W3006291036 hasConcept C102652120 @default.
- W3006291036 hasConcept C118552586 @default.
- W3006291036 hasConcept C126322002 @default.
- W3006291036 hasConcept C15744967 @default.
- W3006291036 hasConcept C2776412080 @default.
- W3006291036 hasConcept C2777330709 @default.
- W3006291036 hasConcept C2778186239 @default.
- W3006291036 hasConcept C2778802184 @default.
- W3006291036 hasConcept C2780494398 @default.
- W3006291036 hasConcept C2780864610 @default.
- W3006291036 hasConcept C71924100 @default.
- W3006291036 hasConceptScore W3006291036C102652120 @default.
- W3006291036 hasConceptScore W3006291036C118552586 @default.
- W3006291036 hasConceptScore W3006291036C126322002 @default.
- W3006291036 hasConceptScore W3006291036C15744967 @default.
- W3006291036 hasConceptScore W3006291036C2776412080 @default.
- W3006291036 hasConceptScore W3006291036C2777330709 @default.
- W3006291036 hasConceptScore W3006291036C2778186239 @default.
- W3006291036 hasConceptScore W3006291036C2778802184 @default.
- W3006291036 hasConceptScore W3006291036C2780494398 @default.
- W3006291036 hasConceptScore W3006291036C2780864610 @default.
- W3006291036 hasConceptScore W3006291036C71924100 @default.
- W3006291036 hasIssue "143" @default.
- W3006291036 hasLocation W30062910361 @default.
- W3006291036 hasOpenAccess W3006291036 @default.
- W3006291036 hasPrimaryLocation W30062910361 @default.
- W3006291036 hasRelatedWork W11075747 @default.
- W3006291036 hasRelatedWork W2009097496 @default.
- W3006291036 hasRelatedWork W2016602126 @default.
- W3006291036 hasRelatedWork W2370458311 @default.
- W3006291036 hasRelatedWork W2990772121 @default.
- W3006291036 hasRelatedWork W3006291036 @default.
- W3006291036 hasRelatedWork W3008574690 @default.
- W3006291036 hasRelatedWork W3033027257 @default.
- W3006291036 hasRelatedWork W4221166301 @default.
- W3006291036 hasRelatedWork W4245148164 @default.
- W3006291036 hasVolume "XXX" @default.
- W3006291036 isParatext "false" @default.
- W3006291036 isRetracted "false" @default.
- W3006291036 magId "3006291036" @default.
- W3006291036 workType "article" @default.